Solara Active Pharma Sciences informs about monitoring agency report

29 Jul 2024 Evaluate

Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with Regulation 82(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, Solara Active Pharma Sciences has informed that it enclosed the Report of the Monitoring Agency for the quarter ended June 30, 2024, issued by CRISIL Ratings, Monitoring Agency appointed to monitor the utilisation of the proceeds of the Rights Issue of the Company.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.